Tag: Bladder Cancer
05 April 2024
EAUTV: Bladder Cancer at EAU24
05 April 2024
Game-changing roles: ctDNA and adjuvant NIVO in advanced BCa treatment
The Game-changing Session “Prime time for adjuvant treatment in locally advanced bladder cancer” led by Prof. Morgan Rouprêt (FR) and
28 March 2024
What’s on the agenda for bladder cancer at EAU24?
We are one week away from EAU24 in Paris! Bladder cancer is well-represented at EAU24, with several dedicated thematic sessions,
13 March 2023
Best of EAU23: Excerpts from the congress’s most crucial updates
Europe’s biggest urological event of the year, the 38th Annual EAU Congress (EAU23), concluded with a special session that encapsulated
11 March 2023
BCa treatment: Is quality of life sacrificed?
Day two of EAU23 kicked off with a Plenary Session on locally advanced bladder cancer (BCa) and the misconception of
11 March 2023
EAUTV: Bladder Cancer at EAU23
This recap of the topic of Bladder Cancer at EAU23 is led by Prof. J. Boormans. He and his co-hosts
02 July 2022
EAUTV: Profs. Morgan Roupret and Ashish Kamat discuss Bladder Cancer
On this episode of EAUTV, Prof. Morgan Roupret and Prof. Ashish Kamat tackle a full day of bladder cancer at
02 July 2022
On recurring and metastatic diseases: Special EAU, EANM, ESMO and ESTRO session
The special joint session of the European Association of Urology (EAU), European Association of Nuclear Medicine (EANM), European Society for
02 July 2022
Plenary Session 4: State-of-the-art lectures overview
Spearheaded by Chair of the EAU Guidelines Office Prof. Dr. Maria Jose Ribal Caparros (ES) and ESOU Chair Prof. Morgan
10 July 2021
EAU TV Day 2: The best of bladder cancer and renal cell carcinoma on Day Three of EAU21
In today’s EAU TV broadcast, EAU Adjunct Secretary-General and Executive Member Science, Prof. Arnulf Stenzl (DE), led discussions on vital
10 July 2021
Looking into the future of treatments for advanced bladder cancer
Scientific efforts of the last decade have produced several novel diagnostic and therapeutic opportunities for patients suffering from muscle-invasive bladder
09 July 2021
Urine biomarkers for treatment response
Considerable unmet biomarker potential exists in the treatment of bladder cancer By Dr. Patrick Hensley (Houston, US) & Dr. Ashish M. Kamat (Houston,
05 July 2021
Immunotherapy for metastatic urothelial cancer
New agents are expected to significantly improve overall prognosis By Dr. Ursula Vogl (Bellinzona, CH), medical oncologist at Ospedale San Giovanni